Background and Objective: Bacterial Urinary Tract Infection (BUTI) is more prevalent in uncontrolled diabetic patients. However, its significance is not entirely unknown. Further more BUTI treatments are usually empirical without the performance of urine culture and sensitivity. This study has aimed to determine the prevalence of BUTI and to identify their possible risk factors. Antibiotics commonly used to treat BUTI. Materials and Methods: A total of 106 Yemeni diabetic patients among males and females were recruited into the crosssectional study. This study was conducted at the diabetic clinics of Ibn-Sina General Hospital in Al-Mukalla, Yemen, from 1st January-30th March, 2020. Socio-demographic and clinical data were taken from each participant using pre-tested questionnaires. Sterile midstream urine samples were collected and analyzed using microscopy and urine reagent pinstripe. Urine samples were inoculated on MacConkey agar, Cystine Lactose Electrolyte Deficient (CLED), blood agar, chocolate medium with a calibrated loop to determine Colony Forming Units (CFU). Identification of isolates has been done by gram stain and different biochemical tests. Data was analyzed by using SPSS statical analysis. Results: The prevalence of BUTI was significantly higher in females than males (p = 0.002). Staphylococcus aureus was the most common organism (57.9%), followed by Escherichia coli (31.6%). On the other hand diabetic patients with BUTI had significantly increased HbA1c (p<0.051). Conclusion: To sum up bacterial Urinary Tract Infection (BUTI) was more prevalent in people with diabetes mellitus and higher in females than males. Thus, the presence of BUTI can be considered as a risk factor for subsequent symptomatic UTI.
No takes yet. Share an insight, caveat, or question.
Barahim et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: